Biotech
The latest news about Biotech: headlines, AI summaries and the full story from every source.
- Novavax Raises Full-Year Revenue Guidance Following Q3 Earnings Beat
- Geron Corporation Reaches Profitability in Q3 2026 Driven by Rytelo Sales
- OpenAI Acquires Orchestra Bio to Enhance Biotech Capabilities
- OpenAI Acquires Orchestra Bio, a Biotech Startup
- AnaptysBio and GSK Receive FDA Label Expansion for Jemperli in Rectal Cancer
- Disc Medicine shares rise ahead of Phase 3 APOLLO trial results
- Gilead Sciences Receives Multiple FDA Approvals and Label Expansions
- Cathie Wood Increases Stake in CRISPR Therapeutics Amid Strategic Developments
- Intero Biosystems Wins Startup Battlefield at TechCrunch Disrupt 2026
- Lakefront Biotherapeutics Sells Early-Stage CAR-T Programs to Armed Cell Therapeutics
- Arrowhead Pharmaceuticals Reports Positive Trial Data for Alzheimer’s Drug
- AbbVie releases phase 3 induction therapy data on injectable Skyrizi for Crohn's
- Nurix Therapeutics Reports Strong Q3 Earnings and Revenue Growth
- Midday Market Movers: eBay, Sandisk, Meta Platforms, IonQ, Lumentum Among Stocks Reacting to News
- TRex Bio Closes Flat on First Day of Trading Despite Strong After-Hours Performance
- Retension Pharmaceuticals Prices Upsized IPO at $12 per Share
- Northwest Biotherapeutics partners with NHSBT to expand DCVax-L production
- Pacira BioSciences Shares Rise Over 44% Following Acquisition by Viatris
- Iambic Therapeutics Plans IPO with Valuation Over $800 Million
- Vinci Pharmaceuticals Closes Over $8 Million Series A Financing to Develop EPIPLANT™ Drug Delivery Platform
- Argenx Announces Discontinuation of Late-Stage Trial, Stock Drops
- Isomorphic Labs, Spinout from Google DeepMind, Considering Funding Round with Valuation Between $40B and $50B
- vTV Therapeutics' Sickle Cell Candidate HPPD Receives FDA Orphan Drug Designation
- Caribou Biosciences Announces Strategic Review Amid Downgrades
- Rocket Pharmaceuticals Advances Phase 2 Trial for RP-A501 in Danon Disease
- AmyriAD Therapeutics Acquires Recognify Life Sciences to Expand Cognition Pipeline
- Caribou Biosciences to Discontinue CAR-T Programs and Explore Strategic Alternatives
- TRex Bio Aims for $133 Million IPO with Support from Eli Lilly
- BTIG Downgrades Personalis Following Tempus Acquisition
- ArriVent BioPharma Stock Drops Over 50% After Late-Stage Cancer Trial Fails
- MapLight Therapeutics Co-Founder Dr. Karl Deisseroth Wins 2026 Nobel Prize in Medicine
- Vaxcyte Shares Rise on Positive Phase 3 Data for Pneumonia Vaccine Candidate
- Alector Announces Licensing Agreement for Parkinson's Treatment Program
- Moderna Stock Surges Amid Positive Cancer Vaccine News
- Big Pharma Companies Partner with Chinese Biotechs Amid Patent Expirations
- Novartis Enters Licensing Agreement with Abogen for RNA Therapeutics
- Bristol-Myers Squibb vs. Johnson & Johnson: Quarterly Revenue Comparison
- Nektar Therapeutics Shares Drop After Mid-Stage Hair Loss Drug Data Release
- Regeneron Reports Mixed Results in Ovarian Cancer Therapy Trial
- Foghorn Therapeutics Stock Drops Nearly 50% After Ending Collaboration With Eli Lilly
- MoonLake Immunotherapeutics Submits BLA for Sonelokimab to Treat Hidradenitis Suppurativa
- Celcuity Stock Rises on Launch of First Commercial Product
- Citi Downgrades Moderna Amid Concerns Over Valuation and Cancer Drug Sales Expectations
- Beam Therapeutics Sues Chinese Firm YolTech and Partner Serapha for Alleged Trade Secret Theft
- Wave Life Sciences to Receive $12M Milestone Payment from GSK
- Grail's Stock Surges After FDA Advisory Committee Endorses Multi-Cancer Early Detection Test
- Capricor shares rise after new data on deramiocel presented at muscle society congress
- Pyxis Oncology Launches Stock Offering for Phase 3 Cancer Trial
- Kodiak Sciences Shares Surge After Positive Phase 3 Trial Results for Wet AMD Treatments
- Moderna Stock Surges Over 550% Amid Cancer Vaccine Hype; Is It Too Late to Buy?